Virax Biolabs Group (VRAX) Stock Chart & Stock Price History $0.78 -0.01 (-1.05%) Closing price 08/19/2025 03:51 PM EasternExtended Trading$0.76 -0.01 (-1.55%) As of 08/19/2025 07:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Virax Biolabs Group Stock Price Performance The Virax Biolabs Group (VRAX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 78.23%, with a year-to-date return of -65.56%. In the past month, the stock has decreased 19.32%, reflecting recent market activity. As of the latest close, Virax Biolabs Group traded at $0.78 with a market cap of $3.36 million and volume of 20,460 shares. Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+0.65%1 Month Performance-19.32%3 Month Performance-29.22%Year-To-Date Performance-65.56%1 Year Performance-78.23% VRAX Stock Chart for Wednesday, August, 20, 2025 VRAX Chart by TradingView Virax Biolabs Group Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/19/2025$0.78$0.78-1.05%$0.79$0.7620,460 shs$3.36 million08/18/2025$0.77$0.78+1.71%$0.79$0.7413,058 shs$3.40 million08/15/2025$0.75$0.77+3.08%$0.80$0.7423,250 shs$3.34 million08/14/2025$0.75$0.75-0.43%$0.80$0.7345,778 shs$3.24 million08/13/2025$0.78$0.75-3.29%$0.78$0.7263,333 shs$3.26 million08/12/2025$0.76$0.78+2.07%$0.79$0.7540,771 shs$3.37 million08/11/2025$0.79$0.76-3.31%$0.80$0.7618,282 shs$3.30 million08/08/2025$0.79$0.79-0.38%$0.81$0.7822,274 shs$3.41 million08/07/2025$0.79$0.79+0.48%$0.80$0.7912,810 shs$3.42 million08/06/2025$0.78$0.79+1.04%$0.82$0.7762,658 shs$3.41 million Get the Latest News and Ratings for VRAX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. 08/05/2025$0.84$0.78-7.49%$0.85$0.7560,266 shs$3.37 million08/04/2025$0.85$0.84-0.62%$0.90$0.8236,687 shs$3.65 million08/01/2025$0.81$0.85+4.33%$0.88$0.8176,992 shs$3.67 million07/31/2025$0.88$0.81-8.32%$1.00$0.78552,485 shs$3.52 million07/30/2025$0.93$0.88-4.67%$0.99$0.88310,624 shs$3.84 million07/29/2025$0.95$0.93-2.73%$0.99$0.9235,481 shs$4.02 million07/28/2025$0.99$0.95-3.64%$1.03$0.95150,482 shs$4.14 million07/25/2025$1.03$0.99-3.99%$1.03$0.97158,010 shs$4.29 million07/24/2025$1.00$1.03+3.47%$1.10$0.99354,873 shs$4.47 million07/23/2025$1.02$1.00-1.92%$1.05$1.0089,309 shs$4.41 million07/22/2025$1.11$1.02-8.56%$1.10$0.97223,963 shs$4.41 million07/21/2025$0.96$1.11+15.55%$1.14$0.97289,950 shs$4.82 million Related Companies Lixte Biotechnology Stock Chart NextCure Stock Chart TherapeuticsMD Stock Chart Ernexa Therapeutics Stock Chart Incannex Healthcare Stock Chart Bullfrog AI Stock Chart Carisma Therapeutics Stock Chart Synaptogenix Stock Chart COSCIENS Biopharma Stock Chart GeoVax Labs Stock Chart Receive VRAX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Virax Biolabs Group and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VRAX) was last updated on 8/20/2025 by MarketBeat.com Staff From Our PartnersWinning the AI WarWhat’s really driving the trade wars, reshoring, and sweeping executive orders? According to Porter Stansberry...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virax Biolabs Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Virax Biolabs Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access